Tuuli M.
- Country
- Estonia
- Department
- Children's Clinic
Research Overview
- A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia
- Prospective Evaluation of Model-Informed Precision Dosing of Vancomycin Hydrochloride in Critically Ill Adults with Serious Infections
- Evaluation of Allopurinol Sodium and Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy: Impact on Neurodevelopmental Outcomes
Data & Insights
Has run more than one trial at 1 of 11 partner sites.
Specializations
Critical Care Medicine
Specializes in optimizing treatment approaches for critically ill adults with a particular focus on antimicrobial therapy and precision medicine applications.
- Vancomycin treatment optimization
- Model-informed precision dosing
- Serious infection management
Develops innovative approaches to antibiotic dosing in intensive care settings.
Respiratory Infections
Focuses on treating nosocomial pneumonia with expertise in evaluating novel therapeutic combinations for hospital-acquired infections.
- Hospital-acquired pneumonia treatment
- Antimicrobial combination therapy
- Pediatric respiratory infections
Addresses complex respiratory infections in pediatric populations using advanced therapeutic agents.
Neonatal Medicine
Specializes in treating hypoxic-ischemic encephalopathy in newborns, with expertise in therapeutic hypothermia and neuroprotective interventions.
- Neonatal brain injury treatment
- Neurodevelopmental outcomes
- Birth complication management
Implements innovative therapeutic strategies for improving long-term neurological outcomes in newborns.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.